FDA advisers narrowly back first gene therapy for muscular dystrophy

A panel of experts voted 8-6 in favor of Food and Drug Administration approval of the first gene therapy for Duchenne muscular dystrophy, a fatal genetic disease.

(Image credit: Sarah Silbiger/Getty Images)